Maplight Therapeutics details stock transactions

Maplight Therapeutics, Inc. is the issuer in a notice that lists its common stock alongside Jefferies LLC, with figures of 16,508 and 625,818.28 reported together with a date of 07/15/2026 and a reference to Nasdaq.

Rhea-AI Filing Summary

Maplight Therapeutics, Inc. is the issuer in a notice that lists its common stock alongside Jefferies LLC, with figures of 16,508 and 625,818.28 reported together with a date of 07/15/2026 and a reference to Nasdaq.

The disclosure links several Restricted Stock Unit Grant entries for Maplight Therapeutics, Inc. to quantities of 1,668 (07/30/2023), 853 (11/09/2023), 3,012 (05/02/2024) and 27,484 (07/18/2025). It also shows Kris Hanson as having sold common stock during the past three months, including two entries of 13,917 with associated figures up to 419,224.02.

Key Figures

Quantity linked to Jefferies LLC row: 16508 Amount linked to Jefferies LLC row: 625818.28 RSU grant quantity 07/30/2023: 1668 +5 more

8 metrics

Quantity linked to Jefferies LLC row 16508 Figure listed with Jefferies LLC and Maplight common stock dated 07/15/2026 and Nasdaq

Amount linked to Jefferies LLC row 625818.28 Amount reported alongside the 16508 entry for Maplight common stock and Nasdaq

RSU grant quantity 07/30/2023 1668 Restricted Stock Unit Grant dated 07/30/2023 for Maplight Therapeutics, Inc.

RSU grant quantity 11/09/2023 853 Restricted Stock Unit Grant dated 11/09/2023 for Maplight Therapeutics, Inc.

RSU grant quantity 05/02/2024 3012 Restricted Stock Unit Grant dated 05/02/2024 for Maplight Therapeutics, Inc.

RSU grant quantity 07/18/2025 27484 Restricted Stock Unit Grant dated 07/18/2025 for Maplight Therapeutics, Inc.

Sale quantity 05/11/2026 13917 Common stock entry for Kris Hanson on 05/11/2026 with associated figure 419224.02

Largest associated sale figure 419224.02 Highest amount shown in securities sold during the past 3 months section

Key Terms

Restricted Stock Unit Grant, Securities To Be Sold, Securities Sold During The Past 3 Months, Nasdaq

4 terms

Restricted Stock Unit Grant financial

"Common | 07/30/2023 | Restricted Stock Unit Grant | Maplight"

Securities To Be Sold financial

"144: Securities To Be Sold Common | 07/30/2023 | Restricted"

Securities Sold During The Past 3 Months financial

"144: Securities Sold During The Past 3 Months Kris Hanson"

Nasdaq market

"42620000 | 07/15/2026 | Nasdaq 144: Securities"

The Nasdaq is a stock exchange where many companies' shares are bought and sold, functioning much like a marketplace for investments. It matters to investors because it provides a platform to buy and sell ownership stakes in companies, helping them track the value of those companies and make informed decisions. As one of the largest and most technology-focused markets, it also reflects trends and developments in the business world.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What common stock information for MPLT is highlighted in this notice?

The notice highlights common stock of Maplight Therapeutics, Inc. linked to Jefferies LLC, with figures of 16,508 and 625,818.28, a date of 07/15/2026, and a Nasdaq reference, indicating quantified activity in this security.

Which restricted stock unit grants for Maplight Therapeutics (MPLT) are referenced?

Several Restricted Stock Unit Grant entries are listed for Maplight Therapeutics, Inc.: 1,668 on 07/30/2023, 853 on 11/09/2023, 3,012 on 05/02/2024 and 27,484 on 07/18/2025, all tied to the company’s common stock.

What recent common stock sales for MPLT involving Kris Hanson are reported?

The past three months section shows Kris Hanson associated with common stock sales dated 04/15/2026, 04/16/2026, 05/04/2026 and 05/11/2026, including two larger entries of 13,917 each with related figures of 388,135.11 and 419,224.02.

Which broker and exchange are connected to MPLT common stock in this disclosure?

Jefferies LLC, located at 520 Madison Avenue, 4th Floor, New York, NY 10022, is listed alongside Maplight Therapeutics common stock. The entry also references Nasdaq and includes a date of 07/15/2026 for that common stock row.

What is the largest figure reported in the MPLT past three months sales section?

In the securities sold during the past three months section for Kris Hanson, the largest associated figure is 419,224.02, linked to a common stock entry of 13,917 dated 05/11/2026, indicating the highest single reported transaction amount there.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/15/2026 - 04:11 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001789970
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	MapLight Therapeutics, Inc.
SEC File Number	001-42914
Address of Issuer	800 CHESAPEAKE DRIVE REDWOOD CITY CALIFORNIA 94063
Phone	650-839-4360
Name of Person for Whose Account the Securities are To Be Sold	Hanson Kristopher
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Jefferies LLC 520 Madison Avenue 4th Floor New York NY 10022	16508	625818.28	42620000	07/15/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/30/2023	Restricted Stock Unit Grant	Maplight Therapeutics, Inc.			1668	07/30/2023	N/A
Common	11/09/2023	Restricted Stock Unit Grant	Maplight Therapeutics, Inc.			853	11/09/2023	N/A
Common	07/18/2025	Restricted Stock Unit Grant	Maplight Therapeutics, Inc.			27484	07/18/2025	N/A
Common	05/02/2024	Restricted Stock Unit Grant	Maplight Therapeutics, Inc.			3012	05/02/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Kris Hanson 800 Chesapeake Drive Redwood City CA 94063	Common	05/11/2026	13917	419224.02
Kris Hanson 800 Chesapeake Drive Redwood City CA 94063	Common	05/04/2026	13917	388135.11
Kris Hanson 800 Chesapeake Drive Redwood City CA 94063	Common	04/16/2026	298	8156.77
Kris Hanson 800 Chesapeake Drive Redwood City CA 94063	Common	04/15/2026	1529	40974.77

144: Remarks and Signature

Remarks	Shares to be sold solely to satisfy tax withholding obligations in connection with RSU vesting.
Date of Notice	07/15/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Kristopher Hanson
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)